<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Microbiol Rev</journal-id><journal-id journal-id-type="iso-abbrev">Clin. Microbiol. Rev</journal-id><journal-id journal-id-type="pmc-domain-id">85</journal-id><journal-id journal-id-type="pmc-domain">cmr</journal-id><journal-id journal-id-type="publisher-id">CMR</journal-id><journal-title-group><journal-title>Clinical Microbiology Reviews</journal-title></journal-title-group><issn pub-type="ppub">0893-8512</issn><issn pub-type="epub">1098-6618</issn><publisher><publisher-name>American Society for Microbiology (ASM)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC7194852</article-id><article-id pub-id-type="pmcid-ver">PMC7194852.1</article-id><article-id pub-id-type="pmcaid">7194852</article-id><article-id pub-id-type="pmcaiid">7194852</article-id><article-id pub-id-type="pmid">32349999</article-id><article-id pub-id-type="doi">10.1128/CMR.00190-19</article-id><article-id pub-id-type="publisher-id">00190-19</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Intrathecal Antibacterial and Antifungal Therapies</article-title><alt-title alt-title-type="running-head">Intrathecal Antibacterial and Antifungal Therapies</alt-title><alt-title alt-title-type="short-authors">Nau et al.</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8316-995X</contrib-id><name name-style="western"><surname>Nau</surname><given-names initials="R">Roland</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref><xref ref-type="aff" rid="aff2"><sup>b</sup></xref><xref ref-type="bio" rid="d38e55">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Blei</surname><given-names initials="C">Claudia</given-names></name><xref ref-type="aff" rid="aff3"><sup>c</sup></xref><xref ref-type="bio" rid="d38e70">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Eiffert</surname><given-names initials="H">Helmut</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref><xref ref-type="aff" rid="aff4"><sup>d</sup></xref><xref ref-type="bio" rid="d38e88">*</xref></contrib><aff id="aff1"><label>a</label><addr-line>Institute of Neuropathology, University Medical Center, G&#246;ttingen, Germany</addr-line></aff><aff id="aff2"><label>b</label><addr-line>Department of Geriatrics, Protestant Hospital G&#246;ttingen-Weende, G&#246;ttingen, Germany</addr-line></aff><aff id="aff3"><label>c</label><addr-line>Hospital Pharmacy, University Medical Center, G&#246;ttingen, Germany</addr-line></aff><aff id="aff4"><label>d</label><addr-line>Amedes MVZ for Laboratory Medicine, Medical Microbiology and Infectiology, G&#246;ttingen, Germany</addr-line></aff></contrib-group><author-notes><corresp id="cor1">Address correspondence to Roland Nau, <email>rnau@gwdg.de</email>.</corresp><fn fn-type="other"><p><bold>Citation</bold> Nau R, Blei C, Eiffert H. 2020. Intrathecal antibacterial and antifungal therapies. Clin Microbiol Rev 33:e00190-19. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1128/CMR.00190-19">https://doi.org/10.1128/CMR.00190-19</ext-link>.</p></fn></author-notes><pub-date pub-type="epub"><day>29</day><month>4</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>7</month><year>2020</year></pub-date><volume>33</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">355233</issue-id><elocation-id>e00190-19</elocation-id><pub-history><event event-type="pmc-release"><date><day>29</day><month>04</month><year>2021</year></date></event><event event-type="pmc-live"><date><day>29</day><month>04</month><year>2021</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2021-04-29 00:16:22.220"><day>29</day><month>04</month><year>2021</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2020 American Society for Microbiology.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>American Society for Microbiology</copyright-holder><license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="asm" xlink:href="https://doi.org/10.1128/ASMCopyrightv2"><license-p><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/ASMCopyrightv2">All Rights Reserved</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="CMR.00190-19.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="CMR.00190-19.pdf"/><abstract abstract-type="precis"><p>Intrathecal administration of anti-infectives is indicated in central nervous system infections by multiresistant pathogens when drugs that can reach adequate cerebrospinal fluid (CSF) concentrations by systemic therapy are not available. Antibiotics that readily pass the blood-brain and blood-CSF barriers and/or that have low toxicity allowing an increase in the daily dosage should not be used for intrathecal therapy. Intrathecal therapy is accompanied by systemic treatment. Antibacterials indispensable for intrathecal therapy include aminoglycosides, colistin, daptomycin, tigecycline, and vancomycin.</p></abstract><abstract><title>SUMMARY</title><p>Intrathecal administration of anti-infectives is indicated in central nervous system infections by multiresistant pathogens when drugs that can reach adequate cerebrospinal fluid (CSF) concentrations by systemic therapy are not available. Antibiotics that readily pass the blood-brain and blood-CSF barriers and/or that have low toxicity allowing an increase in the daily dosage should not be used for intrathecal therapy. Intrathecal therapy is accompanied by systemic treatment. Antibacterials indispensable for intrathecal therapy include aminoglycosides, colistin, daptomycin, tigecycline, and vancomycin. Limited experience suggests the utility of the antifungals amphotericin B and caspofungin. Intraventricular administration ensures distribution throughout the CSF compartment, whereas intralumbar dosing often fails to attain adequate antibiotic concentrations in the ventricles. The individual dose is determined by the estimated size of the CSF space and by the estimated clearance from CSF. For moderately lipophilic anti-infectives with a molecular weight above approximately 1,000 g/mol, as well as for hydrophilic drugs with a molecular weight above approximately 400 g/mol, one daily dose is normally adequate. The ventricular drain should be clamped for 15 to 120 min to facilitate the distribution of the anti-infective in the CSF space. Therapeutic drug monitoring of the trough levels is necessary only in cases of therapeutic failure.</p></abstract><kwd-group><title>KEYWORDS</title><kwd>antibiotics</kwd><kwd>antifungal agents</kwd><kwd>brain abscess</kwd><kwd>cerebrospinal fluid</kwd><kwd>intrathecal</kwd><kwd>intraventricular</kwd><kwd>meningitis</kwd><kwd>ventricular shunt</kwd><kwd>ventriculitis</kwd></kwd-group><funding-group><award-group id="award1"><funding-source><institution-wrap><institution>B. Braun-Stiftung (B. Braun Stiftung)</institution><institution-id>https://doi.org/10.13039/100010345</institution-id></institution-wrap></funding-source><award-id>BBST-D-16-00060</award-id><principal-award-recipient><name name-style="western"><surname>Nau</surname><given-names>Roland</given-names></name></principal-award-recipient></award-group></funding-group><counts><fig-count count="2"/><table-count count="2"/><equation-count count="0"/><ref-count count="140"/><page-count count="24"/><word-count count="16148"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>July 2020</meta-value></custom-meta></custom-meta-group></article-meta><notes notes-type="dedication"><p>This work is dedicated to Hilmar Prange on the occasion of his 75th birthday.</p></notes></front></article></pmc-articleset>